Moreover, NAFLD leads to hepatic insulin resistance by stimulating gluconeogenesis [11], and upregulated SREBP-1c may suppress IRS-2-mediated insulin signaling generating a feedforward machinery to further stimulate or worsen NAFLD [11, 12]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.